Pratteln, Switzerland, May 26, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that its shareholders approved all motions by the…
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00…
Ad hoc announcement pursuant to Art. 53 LR Highlights: Santhera secures approximately CHF 20 million of additional funding from existing…